Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?
Picard Medical stock plunged about 75% to $3.27 by mid-day Oct. 24, after hitting a 52-week high of $13.68 the previous day. The selloff followed an SEC filing authorizing up to 18 million new shares, raising dilution fears. The company recently reported 207% Q2 revenue growth and completed a $19.5 million IPO in September. Analysts cite uncertainty over future growth and dilution.